TP53 and cancer: Further in-depth investigations into the specific mechanisms by which p53 is rapidly recruited to damaged DNA and surrounding chromatin regions to promote chromatin relaxation under DSB damage conditions will provide additional theoretical groundwork for clinical cancer treatment.